RV-Mediated Mechanisms of Neutrophil Motility /Inflammat
RV-Mediated Mechanisms of Neutrophil Motility /Inflammat
批准号:
7151331
负责人:
Anna Huttenlocher
金额:
$18.13万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2011-08-31
关键词:
asthmacalpaincell adhesioncell motilitychemotaxiscooperative studyfluorescencegenetically modified animalshost organism interactionhuman subjectinflammationlaboratory mousemicrofluidicsmolecular /cellular imagingmolecular pathologyneutrophilpathologic processpatient oriented researchrespiratory infectionsrespiratory systemrespiratory virusrhinovirustumor necrosis factor alphavirus infection mechanism
中文摘要
鼻病毒引起的炎症反应以呼吸道占优势为特征。
与哮喘加重程度相关的中性粒细胞。尽管最近有相当多的证据
这支持了中性粒细胞在哮喘发病机制中的重要性,但对
鼻病毒如何调节中性粒细胞功能。这项提案的长期目标是将
呼吸道病毒感染诱导中性粒细胞运动的信号机制
重新聚集到呼吸道,并确定限制病毒诱导的新的治疗靶点
炎症反应。大量证据表明,鼻病毒感染会导致中性粒细胞
间接炎症通过促进呼吸道上皮细胞释放炎症介质来实现。我们
现在有令人兴奋的新数据表明,鼻病毒16也直接影响中性粒细胞信号和
能动性。凭借我们在实时荧光成像方面的成熟专业知识和最近开发的新技术
要使用微流控技术分析趋化性,我们处于独特的位置来检验以下假设。我们
认为鼻病毒通过与中性粒细胞的间接和直接相互作用调节
对中性粒细胞迁移和趋化至关重要的信号通路,从而影响
中性粒细胞在呼吸道中的募集和滞留。我们提出了以下具体目标:一、
阐明中性粒细胞趋化和募集到呼吸道的机制
呼吸道病毒感染。在体外,钙蛋白酶抑制可阻断中性粒细胞对IL-8的趋化作用。在中同时使用
在与项目IV合作的转基因小鼠模型的体外和体内方法中,我们建议
描述钙调蛋白是如何调节中性粒细胞趋化和炎性募集的
体内呼吸道病毒感染。II.剖析鼻病毒调节的分子机制
肿瘤坏死因子α介导的中性粒细胞功能。肿瘤坏死因子α促进停止信号,触发中性粒细胞黏附和
抑制细胞迁移。我们最近的研究表明,鼻病毒干扰了肿瘤坏死因子α介导的作用。在……里面
此外,初步数据表明,鼻病毒可能通过激活ERK直接影响中性粒细胞功能。
和p38标记路径。在项目II和项目V的合作下,我们现在提议解剖分子
鼻病毒调节肿瘤坏死因子α介导的中性粒细胞黏附和信号转导的机制。三、审查
鼻病毒对中性粒细胞运动和趋化作用的影响初步调查结果表明,
鼻病毒通过ICAM-1直接诱导中性粒细胞随机运动并减少趋化迁移
依赖路径..利用时间推移显微镜,我们现在建议剖析
鼻病毒调节中性粒细胞的迁移和趋化作用,并与项目I合作确定
这些机制在易患鼻病毒引起的哮喘恶化的患者中是不同的。
英文摘要
The inflammatory response induced by rhinovirus is characterized by the predominance of airway
neutrophils that correlates with the severity of asthma exacerbation. Despite considerable recent evidence
that supports the importance of neutrophils in the pathogenesis of asthma, there is limited understanding of
how rhinovirus modulates neutrophil function. The long-term goal of this proposal is to characterize the
signaling mechanisms by which respiratory viral infections induce neutrophil motility and
recruitment to the airway, and to identify novel therapeutic targets that limit viral-induced
inflammatory responses. Substantial evidence suggests that rhinovirus infections induce neutrophilic
inflammation indirectly by promoting the release of inflammatory mediators from airway epithelial cells. We
now have exciting new data that indicate that rhinovirus 16 also has direct effects on neutrophil signaling and
motility. With our established expertise in live fluorescent imaging and recently developed novel technology
to analyze chemotaxis using microfluidics, we are uniquely positioned to test the following hypothesis. We
propose that rhinovirus, by both indirect and direct interactions with neutrophils, modulates
signaling pathways critical for neutrophil migration and chemotaxis, and thereby affects the
recruitment and retention of neutrophils in the airway. We propose the following Specific Aims: I.
Elucidate the mechanisms of neutrophil chemotaxis and recruitment to the airway in response to
respiratory viral infection. Calpain inhibition blocks neutrophil chemotaxis to IL-8 in vitro. Using both in
vitro and in vivo approaches with transgenic mouse models in collaboration with Project IV, we propose to
characterize how calpains regulate neutrophil chemotaxis and inflammatory recruitment in response to
respiratory viral infection in vivo. II. Dissect the molecular mechanisms by which rhinovirus modulates
TNFalpha-mediated neutrophil function. TNFalpha promotes a stop signal that triggers neutrophil adhesion and
inhibits cell migration. Our recent studies indicate that rhinovirus perturbs TNFalpha-mediated effects. In
addition, preliminary data indicate that rhinovirus may affect neutrophil function directly via activation of ERK
and p38 MARK pathways. In collaboration with Project II and V, we now propose to dissect the molecular
mechanisms by which rhinovirus modulates TNFalpha-mediated neutrophil adhesion and signaling. III. Examine
the effect of rhinovirus on neutrophil motility and chemotaxis. Preliminary findings indicate that
rhinovirus directly induces neutrophil random motility and reduces chemotactic migration through an ICAM-1-
dependent pathway.. Using time lapse microscopy, we now propose to dissect the mechanisms by which
rhinovirus modulates neutrophil migration and chemotaxis, and in collaboration with Project I determine if
these mechanisms are different in patients susceptible to rhinovirus-induced asthma exacerbation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Imaging Immunometabolism in live animals during host defense
-
批准号:10188913
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2021
-
负责人:Anna Huttenlocher
-
依托单位:
Imaging Immunometabolism in live animals during host defense
-
批准号:10374162
-
项目类别:
-
资助金额:$19.2万
-
财政年份:2021
-
负责人:Anna Huttenlocher
-
依托单位:
Cell migration and wound repair
-
批准号:10395418
-
项目类别:
-
资助金额:$66.98万
-
财政年份:2016
-
负责人:Anna Huttenlocher
-
依托单位:
Cell migration and wound repair
-
批准号:10083493
-
项目类别:
-
资助金额:$66.96万
-
财政年份:2016
-
负责人:Anna Huttenlocher
-
依托单位:
Cell migration and wound repair
-
批准号:10631883
-
项目类别:
-
资助金额:$66.98万
-
财政年份:2016
-
负责人:Anna Huttenlocher
-
依托单位:
Cytoskeletal regulation of T cell-APC interactions
-
批准号:8513565
-
项目类别:
-
资助金额:$40.98万
-
财政年份:2012
-
负责人:Anna Huttenlocher
-
依托单位:
2009 Gradient Sensing & Directed Cell Migration Gordon Research Conference
-
批准号:7608789
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2009
-
负责人:Anna Huttenlocher
-
依托单位:
Regulation of Mast Cell Function by Inhibitory Molecules
-
批准号:7185059
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2006
-
负责人:Anna Huttenlocher
-
依托单位:
Regulation of Mast Cell Function by Inhibitory Molecules
-
批准号:7559542
-
项目类别:
-
资助金额:$30.91万
-
财政年份:2006
-
负责人:Anna Huttenlocher
-
依托单位:
Regulation of Mast Cell Function by Inhibitory Molecules
-
批准号:7356009
-
项目类别:
-
资助金额:$30.92万
-
财政年份:2006
-
负责人:Anna Huttenlocher
-
依托单位:
Regulation of Mast Cell Function by Inhibitory Molecules
-
批准号:7759222
-
项目类别:
-
资助金额:$30.58万
-
财政年份:2006
-
负责人:Anna Huttenlocher
-
依托单位:
LASER SCANNING CYTOMETER
-
批准号:6878180
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2005
-
负责人:Anna Huttenlocher
-
依托单位:
Neutrophil Chemotaxis in Autoinflammation
-
批准号:7111850
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2005
-
负责人:Anna Huttenlocher
-
依托单位:
Neutrophil chemotaxis in autoinflammation
-
批准号:7882400
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2005
-
负责人:Anna Huttenlocher
-
依托单位:
Neutrophil Chemotaxis in Autoinflammation
-
批准号:7479605
-
项目类别:
-
资助金额:$26.49万
-
财政年份:2005
-
负责人:Anna Huttenlocher
-
依托单位:
Neutrophil Chemotaxis in Autoinflammation
-
批准号:8541234
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2005
-
负责人:Anna Huttenlocher
-
依托单位:
Neutrophil Chemotaxis in Autoinflammation
-
批准号:8899567
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2005
-
负责人:Anna Huttenlocher
-
依托单位:
LASER SCANNING CYTOMETER: ASTHMA
-
批准号:7166446
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2005
-
负责人:Anna Huttenlocher
-
依托单位:
Neutrophil chemotaxis in autoinflammation
-
批准号:8309408
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2005
-
负责人:Anna Huttenlocher
-
依托单位:
Neutrophil Chemotaxis in Autoinflammation
-
批准号:7690999
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2005
-
负责人:Anna Huttenlocher
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Wnt5a/Calpain6/Rac1通路激活毛囊黑素干细胞逆转毛发白化的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:星懿展
-
依托单位:
矢车菊素-3-O-葡萄糖苷通过miR-137-3p抑制Calpain-2/β-catenin通路降低胶质瘤细胞干性的信号机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
Calpain活化在线粒体稳态失衡引起噪声性耳蜗损伤中的作用机制
-
批准号:82330034
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:殷善开
-
依托单位:
Calpain通过MYC-DHODH促进铁死亡介导早期心肌损伤在病毒性心肌炎中的作用及机制研究
-
批准号:82370361
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈瑞珍
-
依托单位:
Calpain/P-eIF2α动态平衡在黄芪甲苷IV治疗顺铂肾损伤中的机制研究
-
批准号:82360738
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:寇温
-
依托单位:
热休克蛋白90对calpain-1的变构调节机制及其对鸡肉嫩度的影响
-
批准号:32372406
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:张牧焓
-
依托单位:
靶向抑制线粒体calpain截切ATP5A1蛋白在防治心力衰竭中的关键作用和机制研究
-
批准号:82370388
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:曹婷
-
依托单位:
Calpain调节Kupffer细胞内质网应激介导NLRP3活化促进肝纤维化的机制研究
-
批准号:2023JJ40913
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:杨慧
-
依托单位:
Calpain调控KCC2通路在脑损伤后海马认知功能障碍中的作用及机制
-
批准号:LY23H090012
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:洪远
-
依托单位:
机械敏感离子通道Piezo1通过Ca2+/Calpain途径对类风湿关节炎成纤维样滑膜细胞迁移侵袭的调控和机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:陈冬莹
-
依托单位: